Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Shattuck Labs, Inc. - Common Stock
(NQ:
STTK
)
3.430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Shattuck Labs, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
December 13, 2023
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose,...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Recap: Shattuck Labs Q3 Earnings
November 09, 2023
Via
Benzinga
Earnings Outlook For Shattuck Labs
November 08, 2023
Via
Benzinga
Shattuck Labs: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Analyst Expectations for Shattuck Labs's Future
April 20, 2023
Via
Benzinga
Shattuck Labs Inc. (NASDAQ: STTK) is One of Wednesday Morning’s Most Active Stocks
December 13, 2023
Via
Investor Brand Network
EY Layoffs 2023: What to Know About the Latest EY Job Cuts
December 13, 2023
EY layoffs have been announced and this has the accounting firm cutting 130 jobs to adjust for slowing demand after the pandemic.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Shattuck Labs (STTK) Stock Up 93% Today?
December 13, 2023
Shattuck Labs stock is rising on Wednesday after the company provided positive initial results from a Phase 1 clinical trial.
Via
InvestorPlace
Why Is Blood Cancer-Focused Shattuck Labs Stock Soaring Today?
December 13, 2023
Shattuck Labs Inc (NASDAQ: STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk...
Via
Benzinga
US Stocks Mixed; Producer Prices Unchanged For November
December 13, 2023
U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 13, 2023
Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!
Via
InvestorPlace
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML)
December 13, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation
December 05, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
November 06, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023
November 02, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
September 25, 2023
Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday.
Via
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Via
Benzinga
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 22, 2023
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 22, 2023
Via
Benzinga
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
May 25, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.